Literature DB >> 19133061

The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.

Michel Rossignol1, Abdelilah Abouelfath, Regis Lassalle, Yvon Merlière, Cécile Droz, Bernard Bégaud, Fanny Depont, Yola Moride, Patrick Blin, Nicholas Moore, Annie Fourrier-Réglat.   

Abstract

AIM: The aim of this study was to compare patterns of utilization of NSAIDs for musculoskeletal disorders (MSD) by occupation in a general employed population.
METHODS: This was a secondary analysis of the CADEUS cohort study on 5651 actively employed patients, who submitted at least one claim for the reimbursement of a NSAID dispensation for a MSD between August 2003 and July 2004, in the French National Healthcare Insurance database. Questionnaires were sent to prescribing physicians to obtain diagnoses and the medical history, and to patients for their occupation, height and weight and smoking status. Multivariate logistic regression was used to study the determinants of a heavy use of NSAIDs defined as 'over four dispensations in one year with less than two months between any two'.
RESULTS: Factors associated with heavy use of NSAIDs were age (Odds ratio (OR): 1.8 (ten years), 95% confidence interval (CI): 1.6-1.9), osteoarthritis (versus back pain) (OR: 1.8, 95% CI: 1.5-2.1), body mass index (superior to 30) (OR: 1.8, 95% CI: 1.5-2.2), and occupation (blue collar versus white collar workers) (OR: 1.4, 95% CI: 1.2-1.6). Blue collar workers also had a 20% higher prevalence of 5-year history of dyspepsia. No difference was observed between sexes or in the use of COX-2 selective inhibitors between occupations.
CONCLUSION: Factors associated with occupational constraints that contribute to the severity of MSDs, may explain the heavier use of NSAIDs among blue collar workers in spite of a concurrent and past medical history of adverse reactions to this type of medication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133061      PMCID: PMC2668092          DOI: 10.1111/j.1365-2125.2008.03318.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Prevalence of musculoskeletal activity limitation and associated factors among adults in the general population in the 1998 Quebec Health Survey.

Authors:  Isabelle Leroux; Clermont E Dionne; Renée Bourbonnais; Chantal Brisson
Journal:  J Rheumatol       Date:  2005-09       Impact factor: 4.666

2.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

3.  First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence.

Authors:  L Denoeud; B Mazières; C Payen-Champenois; P Ravaud
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

4.  Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA.

Authors:  Bruno Fautrel; Pascal Hilliquin; Sylvie Rozenberg; François-André Allaert; Philippe Coste; Annette Leclerc; Michel Rossignol
Journal:  Joint Bone Spine       Date:  2005-05       Impact factor: 4.929

5.  Primary osteoarthritis of hip, knee, and hand in relation to occupational exposure.

Authors:  M Rossignol; A Leclerc; F A Allaert; S Rozenberg; J P Valat; B Avouac; P Coste; E Litvak; P Hilliquin
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

6.  The burden of musculoskeletal conditions at the start of the new millennium.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2003

7.  Primary osteoarthritis and occupations: a national cross sectional survey of 10 412 symptomatic patients.

Authors:  M Rossignol; A Leclerc; P Hilliquin; F A Allaert; S Rozenberg; J-P Valat; B Avouac; P Coste; B Savarieau; B Fautrel
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

8.  Prevalence and treatment of diabetes in France: trends between 2000 and 2005.

Authors:  O Kusnik-Joinville; A Weill; B Salanave; P Ricordeau; H Allemand
Journal:  Diabetes Metab       Date:  2008-06-03       Impact factor: 6.041

9.  Increasing response to a postal survey of sedentary patients - a randomised controlled trial [ISRCTN45665423].

Authors:  Roger A Harrison; Don Cock
Journal:  BMC Health Serv Res       Date:  2004-11-10       Impact factor: 2.655

10.  Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Authors:  Yola Moride; Thierry Ducruet; Jean-François Boivin; Nicholas Moore; Sylvie Perreault; Sean Zhao
Journal:  Arthritis Res Ther       Date:  2005-01-17       Impact factor: 5.156

View more
  4 in total

1.  Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.

Authors:  Jean-Pascal Fournier; Agnès Sommet; Robert Bourrel; Stéphane Oustric; Atul Pathak; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

2.  Association Between Male Use of Pain Medication and Fecundability.

Authors:  Amelia K Wesselink; Kathryn A Bresnick; Elizabeth E Hatch; Kenneth J Rothman; Ellen M Mikkelsen; Tanran R Wang; Krista F Huybrechts; Lauren A Wise
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

3.  Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality in hospital admissions.

Authors:  Colin J Crooks; Joe West; Tim R Card
Journal:  Gut       Date:  2011-07-13       Impact factor: 23.059

4.  Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-κB and p38 MAPK.

Authors:  Yazan Ranneh; Abdah Md Akim; Hasiah Ab Hamid; Huzwah Khazaai; Abdulmannan Fadel; Ayman M Mahmoud
Journal:  Nutr Metab (Lond)       Date:  2019-02-27       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.